WEI WANG: Open Payments
NPI 1902813876 · TENAFLY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,193 in 28 payments from 9 companies in 2025. Trend: 2023 $17,569 · 2024 $10,784 · 2025 $6,193
Speaker / faculty: $5,500Food & beverage: $621Education: $71
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $5,765 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $143 |
| Teva Pharmaceuticals USA, Inc. | 2 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Alkermes, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Boston Scientific Corporation | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, COBENFY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, ABILIFY MAINTENA, EXALT Model D.
Industry payments across NJ — which companies pay providers there.
